Follow-up imaging of anal cancer after treatment

[1]  A. Scarsbrook,et al.  Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy , 2022, European Radiology.

[2]  G. Chang,et al.  Survival and Operative Outcomes After Salvage Surgery for Recurrent or Persistent Anal Cancer , 2020, Annals of coloproctology.

[3]  G. Rauch,et al.  MR staging of anal cancer: what the radiologist needs to know , 2019, Abdominal Radiology.

[4]  K. Goodman,et al.  Impact of Surgical Resection on Survival Outcomes After Chemoradiotherapy in Anal Adenocarcinoma. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[5]  Parminder Kaur,et al.  Anal squamous cell carcinoma with metastasis to duodenum causing duodenal stricture and gastric outlet obstruction. , 2019, AME case reports.

[6]  Clarence K. Wong,et al.  Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  R. Madan,et al.  Radiation induced secondary malignancies: a review article , 2018, Radiation oncology journal.

[8]  J. Nuyttens,et al.  Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience , 2018, Annals of Surgical Oncology.

[9]  M. Hauptmann,et al.  Gas-induced susceptibility artefacts on diffusion-weighted MRI of the rectum at 1.5 T - Effect of applying a micro-enema to improve image quality. , 2018, European journal of radiology.

[10]  D. Jonker,et al.  PET imaging in anal canal cancer: a systematic review and meta-analysis. , 2017, The British journal of radiology.

[11]  P. Sharma,et al.  Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. , 2017, The Lancet. Oncology.

[12]  F. Izzo,et al.  Diagnostic performance of magnetic resonance imaging and 3D endoanal ultrasound in detection, staging and assessment post treatment, in anal cancer , 2017, Oncotarget.

[13]  J. Skibber,et al.  Locally Recurrent Disease Related to Anal Canal Cancers. , 2017, Surgical oncology clinics of North America.

[14]  L. Kachnic,et al.  Evolution and Management of Treatment-Related Toxicity in Anal Cancer. , 2017, Surgical oncology clinics of North America.

[15]  R. Ernst,et al.  Diagnosis and Diagnostic Imaging of Anal Canal Cancer. , 2017, Surgical oncology clinics of North America.

[16]  A. Renehan,et al.  The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer , 2016, European Radiology.

[17]  G. Hruby,et al.  The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer : A Systematic Review and Meta-analysis , 2015 .

[18]  S. Yom,et al.  Symptom management during the radiation oncology treatment course: a practical guide for the oncology clinician. , 2014, Seminars in oncology.

[19]  V. Goh,et al.  Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  A. Sharara,et al.  Radiation Enteritis , 2014, Current Gastroenterology Reports.

[21]  V. Goh,et al.  MRI of anal cancer: assessing response to definitive chemoradiotherapy , 2014, Abdominal Imaging.

[22]  Jacqueline Esthappan,et al.  RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. , 2013, International journal of radiation oncology, biology, physics.

[23]  J. Ledermann,et al.  Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. , 2013, The Lancet. Oncology.

[24]  W. Wong,et al.  To PET or not to PET? That is the question. Staging in anal cancer. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  B. Fox,et al.  PET/CT in anal cancer - is it worth doing? , 2012, Clinical radiology.

[26]  Nhue Do,et al.  Radiation Proctitis: Current Strategies in Management , 2011, Gastroenterology research and practice.

[27]  J. Parikh,et al.  Anal carcinomas: the role of endoanal ultrasound and magnetic resonance imaging in staging, response evaluation and follow-up , 2011, European Radiology.

[28]  V. Goh,et al.  Magnetic resonance imaging assessment of squamous cell carcinoma of the anal canal before and after chemoradiation: can MRI predict for eventual clinical outcome? , 2010, International journal of radiation oncology, biology, physics.

[29]  J. Ledermann,et al.  Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I) , 2010, British Journal of Cancer.

[30]  K. Goodman,et al.  Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning. , 2008, International journal of radiation oncology, biology, physics.

[31]  K. Jaeckle.  Neurologic manifestations of neoplastic and radiation-induced plexopathies. , 2010, Seminars in neurology.

[32]  B. Thomas,et al.  MRI of brachial plexopathies. , 2009, Clinical radiology.

[33]  B. O'neill,et al.  Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation. , 2008, The British journal of radiology.

[34]  B. Cummings,et al.  Outcomes of Salvage Surgery for Squamous Cell Carcinoma of the Anal Canal , 2007, Annals of Surgical Oncology.

[35]  J. Ajani,et al.  Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. , 2007, International journal of radiation oncology, biology, physics.

[36]  G. Shah,et al.  MR Imaging of Brachial Plexus , 2004, Topics in magnetic resonance imaging : TMRI.

[37]  H. Sawaf,et al.  Imaging findings after radiotherapy to the pelvis. , 2001, AJR. American journal of roentgenology.

[38]  J. Fleshman,et al.  Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  M. Stamos,et al.  Patterns of recurrence in anal canal carcinoma. , 2000, Archives of surgery.

[40]  Y. Itai,et al.  MR imaging of radiation osteitis in the sacroiliac joints. , 2000, Magnetic resonance imaging.

[41]  P. Logan,et al.  Radiation-induced changes in bone. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.

[42]  H. Bartelink,et al.  Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  I. Kaplan,et al.  Early and late bone-marrow changes after irradiation: MR evaluation. , 1990, AJR. American journal of roentgenology.

[44]  J. Beltrán,et al.  Avascular necrosis of the femoral head: early MRI detection and radiological correlation. , 1987, Magnetic resonance imaging.

[45]  R. Mendelson,et al.  The radiological features of chronic radiation enteritis. , 1985, Clinical radiology.